FDA Proposes To Exempt Dozens Of Devices From 510(k) Requirements
This article was originally published in The Gray Sheet
FDA plans to exempt an array of class II and class I medical devices from premarket submission requirements because the devices are sufficiently well understood and do not present risks that require premarket notification review to assure their safety and effectiveness.
You may also be interested in...
Industry, FDA Agree On Draft User Fee Commitment Letter
Draft commitment and legislative language come one month after agreement “in principle” on MDUFA III reauthorization.
Canadian Generics Group Launches Cost-Saving Campaign
The CGPA is drawing attention to the cost savings Canadians can benefit from through the use of generic drugs via a PSA-style digital campaign.
EU Packaging Regulation Presents Challenge And Opportunity For Consumer Health Industry
A proposed new European Union packaging regulation, which introduces environmental and labelling requirements and extended producer responsibility for medicines, medical devices and food supplements, could be challenging for the region's consumer health industry. But it could also be a spur to creativity, argues Chris Whitehouse, chairman and managing director of Whitehouse Communications.